Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sopharma AD Director's Dealing 2021

Dec 14, 2021

2543_rns_2021-12-14_0aaba398-ea79-4362-8b40-827262e2688f.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Current report №182/2021 Dated 14.12.2021

NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014

"Sopharma" AD (the "Company") announces that it was notified by "Telso" AD related to Vesela Stoeva, that "Telso" AD executed the following transactions related to shares in the Company:

Date and time of
the transaction
Operation Number of
shares
Unit price
(BGN)
13.12.2021 Buy 4 000,00 4,40
13.12.2021 Buy 2 000,00 4,40
13.12.2021 Buy 3 299,00 4,42
13.12.2021 Buy 1 701,00 4,42
13.12.2021 Buy 1 632,00 4,42
13.12.2021 Buy 892,00 4,42
13.12.2021 Buy 2 476,00 4,42
13.12.2021 Buy 857,00 4,42
13.12.2021 Buy 4 143,00 4,42
13.12.2021 Buy 2 523,00 4,42
13.12.2021 Buy 2 477,00 4,42
13.12.2021 Buy 856,00 4,42
13.12.2021 Buy 2 500,00 4,42
13.12.2021 Buy 250,00 4,42
13.12.2021 Buy 3 336,00 4,42
13.12.2021 Buy 297,00 4,42
13.12.2021 Buy 500,00 4,42
13.12.2021 Buy 450,00 4,42
13.12.2021 Buy 1 000,00 4,42
13.12.2021 Buy 1 000,00 4,36
13.12.2021 Buy 2 500,00 4,42
13.12.2021 Buy 350,00 4,42
13.12.2021 Buy 2 000,00 4,42
13.12.2021 Buy 900,00 4,42
13.12.2021 Buy 500,00 4,42
13.12.2021 Buy 500,00 4,42
13.12.2021 Buy 2 000,00 4,42
13.12.2021 Buy 500,00 4,42
13.12.2021 Buy 500,00 4,42
13.12.2021 Buy 90,00 4,40
13.12.2021 Buy 2 500,00 4,42
13.12.2021 Buy 250,00 4,42
13.12.2021 Buy 2 000,00 4,42
13.12.2021 Buy 250,00 4,42
13.12.2021 Buy 250,00 4,42
13.12.2021 Buy 2 000,00 4,42
13.12.2021 Buy 1 000,00 4,42
13.12.2021 Buy 1 750,00 4,42
13.12.2021 Buy 5 000,00 4,42
13.12.2021 Buy 521,00 4,42
13.12.2021 Buy 200,00 4,42

The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade.

Signatures of individuals authorized to represent the Company:

Ognian Donev